SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.

Company Shanghai Shyndec Pharmaceutical Co., Ltd.

600420

CNE000001JG2

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 2026-02-13			5-day change	1st Jan Change
10.63 ^CNY	-1.12%		-0.84%	+5.25%

02-12	Shyndec Pharmaceutical Secures Bids For 51 Drugs in China's Latest Procurement Program	MT
02-09	Shyndec Pharmaceutical's Subsidiary Passes GMP Inspection	MT

Business description: Shanghai Shyndec Pharmaceutical Co., Ltd.

SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research and development, production and sales of pharmaceutical products. The Company's main products are antibiotics, circulatory system drugs and biological products, including garlic oil soft capsules, lecithin soft capsules and deep-sea fish oil soft capsules. Its bulk pharmaceutical chemicals (BPCs) include macrolide antibiotics, antiviral, anti-tumor, cardiovascular, hormones and weight loss drugs. The Company also offers topical preparations, such as gynecological suppositories and dermatology preparations.

Number of employees: 11,472

Sales by Activity: Shanghai Shyndec Pharmaceutical Co., Ltd.

Fiscal Period: December	2020 (CNY)	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)
Pharmaceuticals Segment	12.56B	13.94B	12.96B	12.07B	10.94B

See all business segments

Geographical breakdown of sales: Shanghai Shyndec Pharmaceutical Co., Ltd.

Fiscal Period: December	2020 (CNY)	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)
East China	3.4B	3.69B	3.68B	3.17B	2.81B
Overseas	2.3B	2.84B	2.49B	2.47B	2.58B
North China	1.61B	1.71B	1.75B	1.4B	1.5B
Southern China	1.43B	1.57B	1.2B	1.28B	1.11B
South-West China	1.31B	1.47B	1.48B	1.26B	1.08B
Central China	1.25B	1.25B	1.17B	1.13B	944M
North-West China	561M	564M	541M	573M	422M
North-East China	540M	669M	502M	514M	397M

See all geographic segments

Executive Committee: Shanghai Shyndec Pharmaceutical Co., Ltd.

Manager	Title	Age	Since
Jing Zu DFI	Director of Finance/CFO	56	-
Qian Yin Jing IRC	Investor Relations Contact	46	2019-09-12
Zhong Xi Zhang SEC	Corporate Secretary	50	2024-03-27

See SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. governance

Composition of the Board of Directors: Shanghai Shyndec Pharmaceutical Co., Ltd.

Director	Title	Age	Since
Xiang Dong Yu BRD	Director/Board Member	62	2019-01-30
Peng Wang BRD	Director/Board Member	44	2022-11-27
Yong Liu BRD	Director/Board Member	57	2021-05-16
Shu Yuan Wei BRD	Director/Board Member	62	2020-05-28
Ru Li BRD	Director/Board Member	47	2022-11-27
Fan Hong Wu BRD	Director/Board Member	58	2019-02-12
Kan Tian BRD	Director/Board Member	63	2019-02-12
Ying Qi Li BRD	Director/Board Member	50	2022-11-27
Yong Gang Xing CHM	Chairman	50	2019-11-24
Yong Hua Zuo BRD	Director/Board Member	50	2022-11-27

Composition of the Board of Directors

Shareholders: Shanghai Shyndec Pharmaceutical Co., Ltd.

Name	Equities	%	Valuation
China Southern Asset Management Co., Ltd. 0.4726 %	6,338,400	0.4726 %	10 M ¥
China Asset Management Co., Ltd. 0.3555 %	4,768,410	0.3555 %	7 M ¥
China Merchants Fund Management Co., Ltd. 0.2762 %	3,704,805	0.2762 %	6 M ¥
Fullgoal Fund Management Co., Ltd. 0.1573 %	2,109,800	0.1573 %	3 M ¥
Guolian Fund Management Co. Ltd. 0.157 %	2,106,300	0.157 %	3 M ¥

List of SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. shareholders

Company details: Shanghai Shyndec Pharmaceutical Co., Ltd.

Shanghai Shyndec Pharmaceutical Co., Ltd.

378 Jianlu Road

200137, Shanghai

+86 21 6251 0990

http://www.shyndec.com

address Shanghai Shyndec Pharmaceutical Co., Ltd.(600420)

Specialty & Advanced Pharmaceuticals

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	-1.12%	-0.84%	-7.24%	+5.77%	2.06B
MERCK KGAA	+1.91%	+5.23%	-6.68%	-31.51%	65.94B
HALOZYME THERAPEUTICS, INC.	+3.28%	-2.20%	+36.28%	+62.75%	9.34B
KYOWA KIRIN CO., LTD.	+4.73%	+12.01%	+27.75%	-10.75%	9.22B
SK BIOPHARMACEUTICALS CO., LTD.	-3.70%	+0.65%	-12.92%	+62.02%	5.93B
YUHAN CORPORATION	-0.55%	+3.82%	-13.38%	+118.43%	5.6B
INDIVIOR PHARMACEUTICALS, INC.	+2.43%	+0.64%	+251.78%	+47.11%	4.32B
MEZZION PHARMA CO.,LTD.	-2.42%	+4.53%	+414.34%	+1,003.26%	3.06B
SUPERNUS PHARMACEUTICALS, INC.	+1.99%	-1.57%	+29.99%	+31.78%	2.92B
BETTA PHARMACEUTICALS CO., LTD.	-2.59%	-2.84%	-11.81%	-28.58%	2.79B
Average	+0.40%	+0.98%	+70.81%	+126.03%	11.12B
Weighted average by Cap.	+1.57%	+3.83%	+21.55%	+24.61%